Advances of Fibroblast Growth Factor/Receptor Signaling Pathway in Hepatocellular Carcinoma and its Pharmacotherapeutic Targets

Hepatocellular carcinoma (HCC) is a type of primary liver cancer with poor prognosis, and its incidence and mortality rate are increasing worldwide. It is refractory to conventional chemotherapy and radiotherapy owing to its high tumor heterogeneity. Accumulated genetic alterations and aberrant cell...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Haijun, Yang, Jie, Zhang, Ke, Liu, Jia, Li, Yushan, Su, Wei, Song, Na
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8082422/
https://www.ncbi.nlm.nih.gov/pubmed/33935756
http://dx.doi.org/10.3389/fphar.2021.650388

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8082422/
https://www.ncbi.nlm.nih.gov/pubmed/33935756
http://dx.doi.org/10.3389/fphar.2021.650388

Ejemplares similares